Alaris Group Inc., The – Trademark Portfolio

Entity Type: 03

Alaris Group Inc., The holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include THE ALARIS GROUP, INC.. The owner is based in Bloomington, MN.

Bloomington, MN 55437

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Alaris Group Inc., The's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Alaris Group Inc., The have?

Alaris Group Inc., The has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does Alaris Group Inc., The file in?

Alaris Group Inc., The files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Alaris Group Inc., The's most well-known trademarks?

Alaris Group Inc., The's registered trademark portfolio includes well-known marks such as THE ALARIS GROUP, INC.. These are among 1 currently registered trademark in the portfolio.

What is Alaris Group Inc., The's trademark registration success rate?

Alaris Group Inc., The has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.